Rejected at 1:08 a.m. Nov, 01, 2023 ] by dollajas
Author: Cameron
Related Note: 1481335674660
Rationale for change

Resubmission: AMBOSS Epidemiology has this as the exception in classical HL w/ Nodular sclerosis having equal prevalence in men and women. "Exception: ♀ = ♂ in nodular sclerosing HL"
https://next.amboss.com/us/article/mT0Vr2?q=nodular+sclerosing+classical+hodgkin+lymphoma

Additionally, per UpToDate, Nodular Sclerosis HL has comparable incidences between men and women. Peak incidence in young adults while other subtypes have bimodal age distribution. https://www.uptodate.com/contents/hodgkin-lymphoma-epidemiology-and-risk-factors#H3

Rejection reason

check tagged uworld questions and resubmit if it also agrees that incidence is equal. historically has been a high yield association so i am hesitant to change this

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::03_Hodgkin_Lymphoma_SOAP #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::07_Hodgkin_Lymphoma #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Leukemia_and_Lymphoma_Overview #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::06_Lymphoma #PANCE::HEME::neoplasms_premalignancies_malignancies #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::02_Lymphoid_&_Plasma_Cell_Disorders::02_Hodgkin_Lymphoma #AK_Step1_v12::#Pathoma::06_WBC::06_Lymphoma #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::24_Hodgkin_lymphoma::*Subtypes::Classical::Nodular_Sclerosis #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::17_Hodgkin_Lymphoma #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::lymphoma #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#B&B::12_Hematology::03_White_Blood_Cells::03_Hodgkin_Lymphoma #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::05_Hodgkin_Lymphoma #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::lymphoma #AK_Step1_v12::#OME_banner::Clinical::05_Hematology_Oncology::06_Lymphoma #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Leukemia_and_Lymphoma_Overview